Elevated Second Trimester Alpha-Fetoprotein Increases the Risk of Placenta Accreta
Background: Placenta previa-accreta constitutes an increasing clinical problem, whose diagnosis remains challenging in obstetrics. The current work aimed to assess whether second-trimester serum alpha-fetoprotein (AFP) amounts are altered in pregnant women with placenta previa-accreta versus control...
Saved in:
Main Authors: | Fengge Wang (Author), Dongmei Man (Author), Shiguo Liu (Author) |
---|---|
Format: | Book |
Published: |
IMR Press,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pregnancy outcomes of women with elevated second-trimester maternal serum alpha-fetoprotein
by: Ji-Lin Hu, et al.
Published: (2020) -
Mesenchymal Hamartoma With Elevated Alpha-Fetoprotein: A Diagnostic Pitfall
by: Amine Naggar MD, et al.
Published: (2023) -
The relationship between amniotic fluid alpha-fetoprotein, alkaline phosphatase and ferritin in the second trimester of pregnancy and preterm birth
by: Atousa Dabiri Oskoei, et al.
Published: (2019) -
The C677T methylenetetrahydrofolate reductase variant and third trimester obstetrical complications in women with unexplained elevations of maternal serum alpha-fetoprotein
by: Greenberg Cheryl R, et al.
Published: (2004) -
First-trimester abortion complicated with placenta accreta: A systematic review
by: Yeou-Lih Wang, et al.
Published: (2019)